Pfizer did say at the time it believed crisaborole had the potential to reach or exceed peak sales of $2 billion. At this stage we're talking BOT making maybe a few hundred million/yr but with potential, both with SB & the pipeline. Not sure how much of that 'potential' makes it to the sale price.
Bot Chart, page-7662
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $725.6M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 20877 | 2 |
View Market Depth
| Last trade - 09.57am 03/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
Day chart unavailable